Company / Operating Cash Flow
AtriCure, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$57.3M
FY2025
5-year range
-$22.1M / $57.3M
FY2021-FY2025
Trend
+369.8%
vs FY2024
Sector context
#115 of 158
Health Care
What the data says
Operating Cash Flow changed +370% YoY in FY2025, a notable deviation from the 9-year average annual change of +47%.
Based on SEC 10-K filings.
$57M in FY2025.
Improved from $4M to $57M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#115 of 158 in Health CareTop 73% of 158This company $57.3M Sector average $1.0B
▼
-94.4% below sector average
Key checks
Key Insights
- AtriCure, Inc.'s operating cash flow has grown for 3 consecutive years.
- In FY2025, operating cash flow increased 369.8% year-over-year.
- Ranks #115 out of 158 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2022.
Company context
Key Data Points
- Negative profit margin: -9.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $57.3M | +369.8% |
| FY2024 | $12.2M | +172.2% |
| FY2023 | $4.5M | +120.3% |
| FY2022 | -$22.1M | -60.7% |
| FY2021 | -$13.8M | +30.6% |
| FY2020 | -$19.9M | -25.7% |
| FY2019 | -$15.8M | -279.1% |
| FY2018 | -$4.2M | +53.4% |
| FY2017 | -$8.9M | +40.8% |
| FY2016 | -$15.1M | -92.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026